These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2514360)

  • 1. Neurochemical mechanisms involved in behavioral effects of amphetamines and related designer drugs.
    Gold LH; Geyer MA; Koob GF
    NIDA Res Monogr; 1989; 94():101-26. PubMed ID: 2514360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clozapine and cocaine effects on dopamine and serotonin release in nucleus accumbens during psychostimulant behavior and withdrawal.
    Broderick PA; Hope O; Okonji C; Rahni DN; Zhou Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):157-71. PubMed ID: 14687870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential activation of dopamine release in the nucleus accumbens core and shell after acute or repeated amphetamine injections: a comparative study in the Roman high- and low-avoidance rat lines.
    Giorgi O; Piras G; Lecca D; Corda MG
    Neuroscience; 2005; 135(3):987-98. PubMed ID: 16154292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral and neurochemical studies of opioid effects in the pedunculopontine nucleus and mediodorsal thalamus.
    Klitenick MA; Kalivas PW
    J Pharmacol Exp Ther; 1994 Apr; 269(1):437-48. PubMed ID: 8169850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of low dose N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine administration on exploratory and amphetamine-induced behavior and dopamine D2 receptor function in rats with high or low exploratory activity.
    Alttoa A; Kõiv K; Eller M; Uustare A; Rinken A; Harro J
    Neuroscience; 2005; 132(4):979-90. PubMed ID: 15857703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of changes in extracellular dopamine concentrations in the nucleus accumbens during intravenous self-administration of cocaine or d-amphetamine.
    Di Ciano P; Coury A; Depoortere RY; Egilmez Y; Lane JD; Emmett-Oglesby MW; Lepiane FG; Phillips AG; Blaha CD
    Behav Pharmacol; 1995 Jun; 6(4):311-322. PubMed ID: 11224340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral and neurochemical effects of the dopamine transporter ligand 4-chlorobenztropine alone and in combination with cocaine in vivo.
    Tolliver BK; Newman AH; Katz JL; Ho LB; Fox LM; Hsu K; Berger SP
    J Pharmacol Exp Ther; 1999 Apr; 289(1):110-22. PubMed ID: 10086994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Injection of SCH 23390 into the ventral tegmental area blocks the development of neurochemical but not behavioral sensitization to cocaine.
    Steketee JD
    Behav Pharmacol; 1998 Feb; 9(1):69-76. PubMed ID: 9832950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of neurotensin with brain dopamine systems: biochemical and behavioral studies.
    Nemeroff CB; Luttinger D; Hernandez DE; Mailman RB; Mason GA; Davis SD; Widerlöv E; Frye GD; Kilts CA; Beaumont K; Breese GR; Prange AJ
    J Pharmacol Exp Ther; 1983 May; 225(2):337-45. PubMed ID: 6682440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurochemical substrates for opiate reinforcement.
    Koob GF; Vaccarino FJ; Amalric M; Bloom FE
    NIDA Res Monogr; 1986; 71():146-64. PubMed ID: 3025733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for multiple sites within rat ventral striatum mediating cocaine-conditioned place preference and locomotor activation.
    Sellings LH; McQuade LE; Clarke PB
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1178-87. PubMed ID: 16507711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conditioning as a critical determinant of sensitization induced by psychomotor stimulants.
    Pert A; Post R; Weiss SR
    NIDA Res Monogr; 1990; 97():208-41. PubMed ID: 1978927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of a protein synthesis inhibitor into the ventral tegmental area, but not the nucleus accumbens, prevents behavioral sensitization to cocaine.
    Sorg BA; Ulibarri C
    Synapse; 1995 Jul; 20(3):217-24. PubMed ID: 7570353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitization of midbrain dopamine neuron reactivity and the self-administration of psychomotor stimulant drugs.
    Vezina P
    Neurosci Biobehav Rev; 2004 Jan; 27(8):827-39. PubMed ID: 15019432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of chronic cocaine administration on [3H]dopamine uptake in the nucleus accumbens, striatum and frontal cortex of rats.
    Masserano JM; Venable D; Wyatt RJ
    J Pharmacol Exp Ther; 1994 Jul; 270(1):133-41. PubMed ID: 8035309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amphetamine produces sensitized increases in locomotion and extracellular dopamine preferentially in the nucleus accumbens shell of rats administered repeated cocaine.
    Pierce RC; Kalivas PW
    J Pharmacol Exp Ther; 1995 Nov; 275(2):1019-29. PubMed ID: 7473128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurokinin 3 receptor activation potentiates the psychomotor and nucleus accumbens dopamine response to cocaine, but not its place conditioning effects.
    Jocham G; Lauber AC; Müller CP; Huston JP; de Souza Silva MA
    Eur J Neurosci; 2007 Apr; 25(8):2457-72. PubMed ID: 17445241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated intra-ventral tegmental area administration of SKF-38393 induces behavioral and neurochemical sensitization to a subsequent cocaine challenge.
    Pierce RC; Born B; Adams M; Kalivas PW
    J Pharmacol Exp Ther; 1996 Jul; 278(1):384-92. PubMed ID: 8764374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychomotor-stimulant sensitization: a unitary phenomenon?
    Wise RA; Leeb K
    Behav Pharmacol; 1993; 4(4):339-349. PubMed ID: 11224202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enkephalin action on the mesolimbic system: a dopamine-dependent and a dopamine-independent increase in locomotor activity.
    Kalivas PW; Widerlöv E; Stanley D; Breese G; Prange AJ
    J Pharmacol Exp Ther; 1983 Oct; 227(1):229-37. PubMed ID: 6620168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.